Poc Hba1C Testing Market Report 2026

Poc Hba1C Testing Market Overview

• Poc Hba1C Testing market size has reached to $1.02 billion in 2025 • Expected to grow to $1.76 billion in 2030 at a compound annual growth rate (CAGR) of 11.4% • Growth Driver: Increasing Prevalence Of Diabetes Driving Market Growth Due To Higher Demand For Rapid Glycemic Monitoring • Market Trend: Embedding Auto-Checks Technology for Enhanced Test Reliability and Workflow Confidence • North America was the largest region in 2025 and Africa is the fastest growing region.

What Is Covered Under Poc Hba1C Testing Market?

POC HbA1C testing devices are designed to diagnose average levels of glucose in patients’ blood and to control type I and type II diabetes mellitus. Diabetes is a chronic disease that occurs either when an inadequate amount of insulin is produced by the pancreas or when the body cannot use the insulin it produces effectively. This assesses the average level of blood sugar over 2 to 3 months in an individual. The main products of POC Hba1C testing are instruments and consumables. Instruments refer to a measuring device for determining the present value of a quantity under observation. The technologies include ion-exchange HPLC, enzymatic assay, affinity binding chromatography, turbidimetric inhibition immunoassay, and others. The various end-users involved are hospitals, physician offices or outpatient centers, home care providers, and other end-users.

What Is The Poc Hba1C Testing Market Growth Forecast?

The poc hba1c testing market size is expected to see rapid growth in the next few years. It will grow to $1.76 billion in 2030 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to increasing adoption of decentralized diagnostics, rising demand for home care testing solutions, expansion of digital diabetes management programs, growing focus on preventive healthcare, increasing investments in rapid diagnostic technologies. Major trends in the forecast period include increasing adoption of rapid point-of-care hba1c devices, growing use of portable and handheld testing systems, rising demand for home-based diabetes monitoring, expansion of integrated poc diagnostic platforms, enhanced focus on test accuracy and standardization.

Global Poc Hba1C Testing Market Segmentation

1) By Type of Product: Instruments, Consumables 2) By Technology: Ion-Exchange HPLC, Enzymatic Assay, Affinity Binding Chromatography, Immunoassay, Other Technologies 3) By End User: Hospitals, Physician Office Or Outpatient Center, Home Care, Other End Users Subsegments: 1) By Instruments: Handheld HbA1c Testing Devices, Portable HbA1c Analyzers, Desktop HbA1c Testing Systems, Integrated Point Of Care Testing Systems 2) By Consumables: Test Strips, Control Solutions, Reagents, Calibration Solutions, Sample Collection Devices

What Is The Driver Of The Poc Hba1C Testing Market?

The increasing prevalence of diabetes is driving the growth of the point-of-care (POC) HbA1C testing market going forward. Diabetes is a chronic metabolic disorder characterized by elevated blood glucose levels that require continuous monitoring to prevent complications such as neuropathy, cardiovascular disease, and renal impairment. This rise in diabetes cases is driven by factors such as sedentary lifestyles, unhealthy dietary patterns, obesity, and aging populations worldwide. The increasing prevalence of diabetes supports the POC HbA1C testing market by boosting demand for fast, convenient, and accurate glycemic control assessment in clinics, pharmacies, and home-care settings, enabling timely treatment decisions. For instance, in 2025, according to the International Diabetes Federation, a Belgium-based health organization, in 2024, around 589 million adults aged 20-79 were living with diabetes, with the total number projected to reach 853 million by 2050 and with more than 4 in 5 adults with diabetes residing in low and middle income countries. Therefore, the increasing prevalence of diabetes is driving the growth of the POC hba1c testing industry.

Key Players In The Global Poc Hba1C Testing Market

Major companies operating in the poc hba1c testing market are F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Bio-Rad Laboratories Inc, Menarini Group, Danaher Corporation, Tosoh Bioscience Inc, ARKRAY Inc, i-SENS Inc, Abbott Laboratories, Trinity Biotech plc, Aina Blood Monitoring System, Getein Biotech Inc, Sugentech Inc, Alere Inc, EKF Diagnostics, HemoCue, PTS Diagnostics, Osang Healthcare, Ortho Clinical Diagnostics, Ascensia, Platinum Equity (LifeScan), Becton Dickinson and Company, Kainico Ltd, Evia Medical Technologies, Agamatrix Inc, Bionime Corporation

Global Poc Hba1C Testing Market Trends and Insights

Major companies in the point-of-care (POC) HbA1c testing market are increasingly integrating built-in internal verification systems to ensure test accuracy, reduce error risk, and improve trust in near-patient diagnostics. These self-check mechanisms continuously monitor environmental conditions, sample integrity, and assay performance during each test to prevent erroneous results or sample loss. For instance, in July 2024, Siemens Healthineers, a Germany-based company with specializing in medical technology, launched the next-generation point-of-care Atellica DCA Analyser. Atellica DCA Analyzer employs its proprietary Auto-Checks Technology, which runs a suite of internal calibrations and checks throughout the testing process including environmental calibration, airflow and thermal verification, sample volume and integrity check, optical clarity, and precision checks. This automated self-monitoring ensures that every HbA1c result delivered in just 4–5 minutes is of lab-equivalent quality, while reducing the need for constant operator supervision. By embedding these self-checks, the Atellica DCA helps minimize pre-analytical errors, enhance result confidence, and support scale-up of point of care (POC) testing in settings with limited lab infrastructure.

What Are Latest Mergers And Acquisitions In The Poc Hba1C Testing Market?

In February 2024, HemoCue AB, a Sweden-based company that offers point-of-care (POC) testing for HbA1c with its HemoCue HbA1c 501 System, entered a strategic partnership with Novo Nordisk, to improve point-of-care HbA1c testing for children with type 1 diabetes in low- and middle-income countries. Through this partnership, HemoCue will support Novo Nordisk’s Changing Diabetes in Children (CDiC) programme, which provided free life-saving medicine to over 52,000 children last year and aims to reach 100,000 children by 2030. Novo Nordisk is a Denmark-based pharmaceutical company that specializes in developing and producing medicines for serious chronic diseases, most notably diabetes and obesity.

Regional Outlook

North America was the largest region in the POC HbA1C testing market in 2025. Africa is expected to be the fastest-growing region in the forecast- period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Poc Hba1C Testing Market?

The POC HbA1C testing market consists of sales of small instruments, portable instruments, and HbA1C testing devices. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.